(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.41%) $924.25
(0.32%) $0.935
(0.80%) $11.04
(0.13%) $0.800
(-0.32%) $91.87
0.00% $ 0.0000160
Live Chart Being Loaded With Signals
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer...
Stats | |
---|---|
Today's Volume | 2 580.00 |
Average Volume | 40.00 |
Market Cap | 514 912 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2011-05-19 | Berdugo Gad | Buy | 200 000 | Stock Option (Right to Buy) |
2011-09-24 | Berdugo Gad | Sell | 120 000 | Stock Option (Right to Buy) |
2008-07-07 | Katz Steven | Buy | 0 |
INSIDER POWER |
---|
0.00 |
Last 2 transactions |
Buy: 200 000 | Sell: 120 000 |
Volume Correlation
MabCure, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
MabCure, Inc. Correlation - Currency/Commodity
MabCure, Inc. Financials
Annual | 2011 |
Revenue: | $500 000 |
Gross Profit: | $500 000 (100.00 %) |
EPS: | $-0.198 |
FY | 2011 |
Revenue: | $500 000 |
Gross Profit: | $500 000 (100.00 %) |
EPS: | $-0.198 |
FY | 2010 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.0200 |
Financial Reports:
No articles found.
MabCure, Inc.
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators